Daniel E. Bauer

Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy.

Bcl-x(L) complements Saccharomyces cerevisiae genes that facilitate the switch from glycolytic to oxidative metabolism.

Alkylating DNA damage stimulates a regulated form of necrotic cell death.

Akt stimulates aerobic glycolysis in cancer cells.

Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand.

Growth factor regulation of autophagy and cell survival in the absence of apoptosis.

The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation.

ATP citrate lyase is an important component of cell growth and transformation.

ATP citrate lyase inhibition can suppress tumor cell growth.

BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findings.

Update on fetal hemoglobin gene regulation in hemoglobinopathies.

Differentiation of NUT midline carcinoma by epigenomic reprogramming.

Loss-of-function and gain-of-function phenotypes of stomatocytosis mutant RhAG F65S.

Clinicopathologic features and long-term outcomes of NUT midline carcinoma.

Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders.

Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number.

Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis.

Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A.

An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level.

Characterization of genomic deletion efficiency mediated by clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells.

TMEM14C is required for erythroid mitochondrial heme metabolism.